Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?

被引：0
|
作者：
Istemihan, Z. [1 ]
Cavus, B. [1 ]
Bardak, A. E. [2 ]
Kirkoglu, A. M. [2 ]
Kiziltas, C. [2 ]
Silay, R. [2 ]
Senkal, I. V. [1 ]
Imanov, Z. [1 ]
Nuriyev, K. [1 ]
Rustemzade, A. [1 ]
Genc, S. [1 ]
Gulluoglu, M. [3 ]
Ormeci, A. Cifcibasi [1 ]
Demir, K. [1 ]
Besisik, F. [1 ]
Kaymakoglu, S. [1 ]
Akyuz, F. [1 ]
机构：
[1] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Gastroenterohepatol, Istanbul, Turkiye
[2] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Istanbul, Turkiye
[3] Istanbul Univ, Istanbul Fac Med, Dept Pathol, Istanbul, Turkiye
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P316
引用
收藏
页码：456 / 456
页数：1
相关论文
共 50 条
  • [41] Predictors of medication adherence in inflammatory bowel disease
    Ediger, Jason P.
    Walker, John R.
    Graff, Lesley
    Lix, Lisa
    Clara, Ian
    Rawsthorne, Patricia
    Rogala, Linda
    Miller, Norine
    McPhail, Cory
    Deering, Kathleen
    Bernstein, Charles N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (07): : 1417 - 1426
  • [42] Predictors of osteopenia in inflammatory bowel disease.
    Henderson, SD
    Dhaliwal, SS
    Hoffman, NE
    GASTROENTEROLOGY, 2000, 118 (04) : A117 - A117
  • [43] Predictors of receptivity to psychotherapy in inflammatory bowel disease
    Salehi, C.
    Mansfield, K. J.
    Lee, T.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 145 - 145
  • [44] Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis
    Tassone, Daniel
    Basnayake, Chamara
    Wright, Emily
    Lust, Mark
    Kamm, Michael A.
    Niewiadomski, Ola
    Schulberg, Julien
    Flanagan, Emma
    Samyue, Tamie
    Fry, Stephanie
    Malcolm, Ruth
    Stanley, Annalise
    Thompson, Alexander J.
    Connell, William R.
    Ding, Nik S. S.
    INTERNAL MEDICINE JOURNAL, 2024, 54 (03) : 446 - 454
  • [45] Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine
    Fraser, AG
    Orchard, TR
    Robinson, EM
    Jewell, DP
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (07) : 1225 - 1232
  • [46] AGA Clinical Practice Update on Management of Inflammatory Bowel Disease in Patients With Malignancy: Commentary
    Axelrad, Jordan E.
    Hashash, Jana G.
    Itzkowitz, Steven H.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (07) : 1365 - 1372
  • [47] DIAGNOSTIC RADIATION - POSSIBLE FACTOR IN MALIGNANCY IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL-DISEASE
    FAINTUCH, J
    ROGERS, AG
    SOURKES, AM
    CORMACK, DV
    GASTROENTEROLOGY, 1978, 74 (05) : 1033 - 1033
  • [48] THE RISKS OF MALIGNANCY FROM EITHER IMMUNOSUPPRESSION OR DIAGNOSTIC RADIATION IN INFLAMMATORY BOWEL-DISEASE
    FORBES, A
    READING, NG
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1995, 9 (05) : 465 - 470
  • [49] Extra-Colonic Malignancy in Inflammatory Bowel Disease: a Paucity of Recommendations with Weak Evidence
    Simcha Weissman
    Muhammad Aziz
    Matthew R. Baniqued
    Mohamed Ahmed
    Sameh Elias
    Joseph D. Feuerstein
    James H. Tabibian
    Journal of Gastrointestinal Cancer, 2022, 53 : 669 - 673
  • [50] DIAGNOSTIC RADIATION - POSSIBLE FACTOR IN MALIGNANCY IN PATIENTS WITH CHRONIC INFLAMMATORY BOWEL-DISEASE
    ROGERS, AG
    FAINTUCH, J
    SOURKES, AM
    CORMACK, DV
    GASTROENTEROLOGY, 1978, 75 (02) : 345 - 345
12345